Faculty Awards - Faculty of Health Sciences - McMaster University
Faculty Awards - Faculty of Health Sciences - McMaster University
Faculty Awards - Faculty of Health Sciences - McMaster University
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
156<br />
PUBLICATIONS<br />
dehydrogenase kinase content in human skeletal muscle.<br />
Am J Physiol Regu. Integr Comp Physiol 2007;<br />
293(3):R1335-41.<br />
Kaczor J, Hall J, Payne E, Tarnopolsky M. Low intensity<br />
training decreases markers <strong>of</strong> oxidative stress in skeletal<br />
muscle <strong>of</strong> mdx mice. Free Radic Biol Med 2007;<br />
43(1):145-154.<br />
Kley R, Vorgerd M, Tarnopolsky M. Creatine for treating<br />
muscle disorders. Cochrane Database Syst Rev<br />
2007 Jan 24;(1):CD004760.<br />
Marchand I, Tarnopolsky M, Adamo K, Bourgeois J,<br />
Chorneyko K, Graham T. Quantitative assessment <strong>of</strong><br />
human muscle glycogen granules size and number in<br />
subcellular locations during recovery from prolonged<br />
exercise. J <strong>of</strong> Physiol 2007; 58(Pt.2):617-628.<br />
Melov S, Tarnopolsky MA, Beckman K, Felkey K,<br />
Hubbard A. Resistance exercise reverses aging in<br />
human skeletal muscle. PloS ONE 207; 2(5):E465.<br />
Rodriguez MC, MacDonald JR, Mahoney DJ, Parise G,<br />
Beal MF, Tarnopolsky MA. Beneficial effects <strong>of</strong> creatine,<br />
CoQ(10), and lipoic acid in mitochondrial disorders.<br />
Muscle & Nerve 2007; 35:235-242.<br />
Tallon M, Harris R, Maffulli N, Tarnopolsky M.<br />
Carnosine, taurine and enzyme activities <strong>of</strong> human<br />
skeletal muscle fibres from elderly subjects with<br />
osteoarthritis and young moderately active subjects.<br />
Biogerontology 2007; 8(2):129-137.<br />
Tarnopolsky M, Rennie C, Robertshaw H, Fedak-<br />
Tarnopolsky S, Brose A, Devries M, Hamadeh, M.<br />
Influence <strong>of</strong> endurance exercise training and sex on<br />
intramyocellular lipid and mitochondrial ultrastructure,<br />
substrate use and mitochondrial enzyme activity. Am<br />
J Physiol Regul Integr Comp Physiol 2007; 292(3):<br />
R1271-1278.<br />
Tarnopolsky M, Phillips S, Parise G, Varbanov A,<br />
DeMuth J, Stevens P, Qu A, Wang F, Isfort R. Gene<br />
expression, fiber type, and strength are similar<br />
between left and right legs in older adults. J. Gerontol<br />
A. Biol. Sci. Med. Sci, 62(10):1088-95, 2007.<br />
Tarnopolsky M, Zimmer A, Paikin J, Safdar A, Aboud A,<br />
Pearce E, Roy B, Doherty. Creatine monohydrate and<br />
conjugated linoleic acid improve strength and body<br />
composition following resistance exercise in older<br />
adults. PloS ONE, 2(10): E991, 2007.<br />
Wilkinson S, Tarnopolsky M, MacDonald M, MacDonald<br />
J, Armstrong D, Phillips S. Consumption <strong>of</strong> fluid skim<br />
milk promotes greater muscle protein accretion after<br />
resistance exercise than does consumption <strong>of</strong> an isonitrogenous<br />
and isoenergetic soy-protein beverage. Am.<br />
J. <strong>of</strong> Clin. Nut., 85(4): 1031-1040, 2007.<br />
Book Chapters<br />
Maher A, Tarnopolsky MA. Nutritional Implications<br />
<strong>of</strong> Sex and Age Differences in Energy Metabolism In:<br />
Sports Nutrition: Energy Metabolism and Exercise, Ira<br />
Wolinsky & Judy Driskell (eds), CRC Press, Taylor and<br />
Francis Group, Boca, FL 2007.<br />
Timmons B, Tarnopolsky MA. Protein: Quantity and<br />
Quality In: Sports Nutrition: Fats and Protein, Judy A.<br />
Driskell (ed.).CRC Press, Taylor & Francis Group, Boca,<br />
FL 2007.<br />
Tarnopolsky MA. Clinical Use <strong>of</strong> Creatine in<br />
Neuromuscular and Neurometabolic Disorders in<br />
Creatine and Creatine Kinase in <strong>Health</strong> and Disease<br />
In: Subcellular Biochemistry, Volume 46, Gajja S.<br />
Salomons and Markus Wyss (eds.), Springer, The<br />
Netherlands, 2007.<br />
TEO, K.<br />
Publications<br />
Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron<br />
DJ, Kostuk W, Knudtson M, Dada M, Casperson P,<br />
Harris CL, Spertus JA, Shaw L, Chaitman BR, Mancini<br />
GBJ, Berman DS, Gau G, Weintraub WS, on behalf<br />
<strong>of</strong> the COURAGE Trial. The evolving pattern <strong>of</strong> symptomatic<br />
coronary artery disease in the United States<br />
and Canada: Baseline characteristics <strong>of</strong> the Clinical<br />
Outcomes Utilizing Revascularization and Aggressive<br />
DruG (COURAGE) Trial. Am J Cardiol 2007; 99:208-212.<br />
Held C, Gerstein HC, Yusuf S, Zhao F, Hilbrich L,<br />
Anderson C, Sleight P, Teo K, on behalf <strong>of</strong> the<br />
ONTARGET/TRANSCEND Investigators. Glucose levels<br />
predict hospitalization for congestive heart failure in<br />
patients with high cardiovascular risk. Circulation 2007;<br />
115:1371-1375.<br />
Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron<br />
DJ, Kostuk W, Knudtson M, Dada M, Casperson P,<br />
Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz<br />
S, Title LM, Gau G, Blaustein AS, Booth DC, Bates<br />
ER, Spertus JA, Berman DS, Mancini GBJ, Berman<br />
DS, Weintraub WS, on behalf <strong>of</strong> the COURAGE Trial<br />
Research Group. Optimal medical therapy with or<br />
without PCI for stable coronary disease. N Engl J Med<br />
2007; 356:1503-1516.<br />
Razak F, Anand SS, Shannon H, Vuksan V, Davis B,<br />
Jacobs R, Teo KK, McQueen M, Yusuf S and for the<br />
SHARE Investigators. Defining obesity cut points in a<br />
multiethnic population. Circulation 2007; 115:2111-2118.<br />
Bohm M, Buamhakel M, Probstfield JL, Schmeider R,<br />
Yusuf S, Zhao F, Teo K. on behalf <strong>of</strong> the ONTARGET/<br />
TRANSCEND ED-Investigators. Sexual function,<br />
satisfaction, and association <strong>of</strong> erectile dysfunction<br />
with cardiovascular disease and risk factors in<br />
cardiovascular high-risk patients: Substudy <strong>of</strong> the<br />
Ongoing Telmisartan Alone and in Combination with<br />
Ramipril Global Endpoint Trial/Telmisartan Randomized<br />
AssessmenNT Study in ACE-INtolerant Subjects with<br />
Cardiovascular Disease (ONTARGET/TRANSCEND). Am<br />
Heart J 2007; 154:94-101.<br />
Chan KL, Teo K, Tam J, Dumesnil JG, on behalf <strong>of</strong> the<br />
ASTRONOMER Investigators. Rationale, design, and<br />
baseline characteristics <strong>of</strong> a randomized trial to assess<br />
the effect <strong>of</strong> cholesterol lowering on the progression<br />
<strong>of</strong> aortic stenosis: the Aortic Stenosis Progression<br />
Observation: Measuring Effects <strong>of</strong> Rosuvastatin<br />
(ASTRONOMER) Trial. Am Heart J 2007;153:925-931.<br />
Partington SL, Abid S, Teo K, Oczkowski W, O’Donnell<br />
MJ. Pre-admission warfarin use in patients with acute<br />
ischemic stroke and atrial fibrillation: the appropriate<br />
use and barriers to oral anticoagulant therapy. Thromb<br />
Res 2007; 120(5):663-9.<br />
Merchant AT, Anand SS, Kelemen LE, Vuksan V, Jacobs<br />
R, Davis B, Teo K, Yusuf S, for the SHARE and SHARE-<br />
AP Investigators. Carbohydrate intake and HDL in a<br />
multiethnic population. Am J Clin Nutr 2007; 85:225-<br />
230.<br />
Boden WE, O’Rourke RA, Teo KK, Weintraub WS. The<br />
corrected values for duration and frequency <strong>of</strong> angina<br />
at baseline in the clinical outcomes utilizing revascularization<br />
and aggressive drug evaluation trial. Am J<br />
Cardiol 2007; 100:1604.<br />
Topouchian J, Feghali EI, Pannier B, Wang S, Zhao<br />
F, Smetana K, Teo K, Asmar R. Arterial stiffness and<br />
pharmacological interventions – the Transcend Arterial<br />
stiffNess Substudy (TRANS study). Vasc <strong>Health</strong> Risk<br />
Manag 2007; 3:381-7.<br />
TODD, D.<br />
Publication<br />
Todd DC, Armstrong S, D’Silva L, Allen CJ, Hargreave<br />
FE, Parameswaran K. The effect <strong>of</strong> obesity on airway<br />
inflammation – a cross-sectional analysis <strong>of</strong> body mass<br />
index and sputum cell counts. Clin Exp Allergy 2007;<br />
37:1049-1054.<br />
UPTON, A.<br />
Publication<br />
Upton A, Clarke B. Supplementary treatment <strong>of</strong><br />
migraine. Drug Development Research 2007; 68:428-<br />
431.<br />
VENDER, R.<br />
Publications<br />
Shukla R, Vender RB, Alhabeeb A, Salama S, Murphy F.<br />
Miliarial Gout (A New Entity).J Cutan Med Surg 2007;<br />
11(1):31-34.<br />
Lovell P, Vender RB. Management and treatment <strong>of</strong><br />
pruritus. Skin Therapy Lett. 2007 Feb; 12(1):1-6.<br />
Jiaravuthisan MM, Sasseville D, Vender RB, Murphy<br />
F, Muhn CY. Psoriasis <strong>of</strong> the nail: Anatomy, pathology,<br />
clinical presentation, and a review <strong>of</strong> the literature on<br />
therapy. Jour Amer Acad Derm 2007; 57(1):1-27.<br />
VERDU, E.<br />
Publications<br />
Verdu EF, Mauro M, Bourgeois J, Armstrong D.<br />
Clinical onset <strong>of</strong> celiac disease after an episode <strong>of</strong><br />
Campylobacter jejuni enteritis. Can J Gastroenterol.<br />
2007 Jul; 21(7):453-5.<br />
Verma-Gandhu M, Verdu EF, Bercik P, Blennerhassett<br />
PA, Al-Mutawaly N, Ghia JE, Collins SM. Visceral pain<br />
perception is determined by the duration <strong>of</strong> colitis and<br />
associated neuropeptide expression in the mouse. Gut.<br />
2007 Mar; 56(3):358-64.<br />
Verma-Gandhu M, Verdu EF, Cohen-Lyons D, Collins<br />
SM.Lymphocyte-mediated regulation <strong>of</strong> betaendorphin<br />
in the myenteric plexus. Am J Physiol<br />
Gastrointest Liver Physiol. 2007 Jan; 292(1):G344-8.<br />
WALKER, I.<br />
Publications<br />
Arnold DM, Webert KE, Carruthers J, Almonte T, Decker<br />
K, Seroski W. Reed J. Chan AKC, Pai M, Walker I.<br />
Trends in the utilization and wastage <strong>of</strong> coagulation<br />
factor concentrates: the application <strong>of</strong> a regional tracking<br />
programme. Haemophilia 2007; 13(3):271-8.<br />
Webert KE, Arnold DM, Carruthers J, Molanar L,<br />
Almonte T, Decker K, Seroski W, Reed J, Chan AK, Pai<br />
M, Walker IR. Utilization <strong>of</strong> recombinant activated factor<br />
VII in southern Ontario in 85 patients with and without<br />
haemophilia. Haemophilia 2007; 13:518-526.<br />
James PD, Notley C, Hegadorn C, Poon MC, Walker<br />
I, Rapson D, Lillicrap D. Association <strong>of</strong> Hemophilia<br />
Clinic Directors <strong>of</strong> Canada. Challenges in defining type<br />
2M von Willebrand disease: Results from a Canadian<br />
cohort study. Journal <strong>of</strong> Thrombosis and Haemostasis<br />
2007; 5:1914-1922.<br />
Selleng K, Warkentin TE, Greinacher A, et al. Very<br />
severe thrombocytopenia and fragmentation hemolysis<br />
mimicking thrombotic thrombocytopenic purpura<br />
associated with a giant intracardiac vegetation infected<br />
with Staphylococcus epidermidis: Role <strong>of</strong> monocyte<br />
procoagulant activity induced by bacterial supernatant.<br />
Am J Hematol. 2007; 82:766-771.<br />
WARKENTIN, T.<br />
Publications<br />
Warkentin TE, Sheppard JI. Clinical sample investigation<br />
(CSI) hematology: pinpointing the precise onset<br />
<strong>of</strong> heparin-induced thrombocytopenia (HIT). J Thromb<br />
Haemost 2007; 5:636-637.<br />
Selleng K, Warkentin TE, Greinacher A, Morris AM,<br />
Walker IR, Heggtveit HA, Eichler P, Cybulsky IJ. Very<br />
severe thrombocytopenia and fragmentation hemolysis<br />
mimicking thrombotic thrombocytopenic purpura<br />
associated with a giant intracardiac vegetation infected<br />
with Staphyloccus epidermidis: role <strong>of</strong> monocyte procoagulant<br />
activity induced by bacterial supernatant.<br />
Am J Hematol 2007; 82:766-771.<br />
Warkentin TE. Drug-induced immune-mediated thrombocytopenia—from<br />
purpura to thrombosis. N Engl J<br />
Med 2007; 356(9):891-893.<br />
Selleng K, Warkentin TE, Greinacher A. Heparininduced<br />
thrombocytopenia in intensive care patients.<br />
Crit Care Med 2007; 35:1165-1176.<br />
Greinacher A, Juhl D, Strobel U, Wessel A, Lubenow<br />
N, Selleng K, Eichler P, Warkentin TE. Heparin-induced<br />
thrombocytopenia: a prospective study on the incidence,<br />
platelet-activating capacity and clinical significance<br />
<strong>of</strong> anti-PF4/heparin antibodies <strong>of</strong> the IgG, IgM,<br />
and IgA classes. J Thromb Haemost 2007; 5:1666-1673.<br />
Neira VM, Sawchuk C, Bonneville KS, Chu V, Warkentin<br />
TE. Case report: Management <strong>of</strong> immediate post-cardiopulmonary<br />
bypass massive intra-cardiac thrombosis.<br />
[Prise en charge d’une thrombose intracardiaque<br />
majeure immédiatement après la circulation extra-corporelle.]<br />
Can J Anaesth 2007; 54:461-466.